# Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder

> **NCT00838227** · PHASE2 · WITHDRAWN · sponsor: **Manhattan Psychiatric Center**

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** modafinil

## Key facts

- **NCT ID:** NCT00838227
- **Lead sponsor:** Manhattan Psychiatric Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-02
- **Primary completion:** 2012-01
- **Final completion:** 2012-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No source of funding to implement the study.
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00838227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00838227, "Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00838227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*